Characteristic phenotypes associated with congenital dyserythropoietic anemia (type II) manifest at different stages of erythropoiesis

Haematologica

Volumn 98, Issue 11, 2013, Pages 1788-1796

  Satchwell, Timothy J ^a   Pellegrin, Stephanie ^a   Bianchi, Paola ^b   Hawley, Bethan R ^a   Gampel, Alexandra ^a   Mordue, Kathryn E ^a   Budnik, Annika ^c   Fermo, Elisa ^b   Barcellini, Wilma ^b   Stephens, David J ^a   van den Akker, Emile ^d   Toye, Ashley M ^a,e  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d SANQUIN RESEARCH   (Netherlands)

^e NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL EXPANSION; CELL ISOLATION; CENTRIFUGATION; CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE 2; CONTROLLED STUDY; CYTOSPIN; ENDOPLASMIC RETICULUM STRESS; ERYTHROBLAST; ERYTHROBLAST LYSATE; ERYTHROCYTE GHOST; ERYTHROPOIESIS; GENE; GENE EXPRESSION; GENE MAPPING; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN GLYCOSYLATION; SEC23B GENE; SECRETORY PATHWAY; TRANSMISSION ELECTRON MICROSCOPY;

ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; ANIMALS; CELLS, CULTURED; ERYTHROPOIESIS; HUMANS; MICE; MICE, INBRED C57BL; PHENOTYPE;

EID: 84887001883     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.085522     Document Type: Article

References (51)

1. Wickramasinghe SN. Congenital dyserythropoietic anaemias: clinical features, haematological morphology and new biochemical data. Blood Rev. 1998; 12(3): 178-200.
2. Khoriaty R, Vasievich MP, Ginsburg D. The COPII pathway and hematologic disease. Blood. 2012; 120(1): 31-8.
3. Iolascon A, Esposito MR, Russo R. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach. Haematologica. 2012; 97(12): 1786-94.
4. Anselstetter V, Horstmann HJ, Heimpel H. Congenital dyserythropoietic anaemia, types I and II: aberrant pattern of erythrocyte membrane proteins in CDA II, as revealed by two-dimensional polyacrylamide gel electrophoresis. Br J Haematol. 1977; 35(2): 209-15.
5. Baines AJ, Banga JP, Gratzer WB, Linch DC, Huehns ER. Red cell membrane protein anomalies in congenital dyserythropoietic anaemia, type II (HEMP AS). Br J Haematol. 1982; 50(4): 563-74.
6. Scartezzini P, Forni GL, Baldi M, Izzo C, Sansone G. Decreased glycosylation of band 3 and band 4. 5 glycoproteins of erythrocyte membrane in congenital dyserythropoietic anaemia type II. Br J Haematol. 1982; 51(4): 569-76.
7. Mawby WJ, Tanner MJ, Anstee DJ, Clamp JR. Incomplete glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (CDA II). Br J Haematol. 1983; 55(2): 357-68.
8. Alloisio N, Texier P, Denoroy L, Berger C, Miraglia del Giudice E, Perrotta S, et al. The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anemia (type II) originate from the endoplasmic reticulum. Blood. 1996; 87(10): 4433-9.
9. Schwarz K, Iolascon A, Verissimo F, Trede NS, Horsley W, Chen W, et al. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet. 2009; 41(8): 936-40.
10. Bianchi P, Fermo E, Vercellati C, Boschetti C, Barcellini W, Iurlo A, et al. Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene. Hum Mutat. 2009; 30(9): 1292-8.
11. Iolascon A, Russo R, Esposito MR, Asci R, Piscopo C, Perrotta S, et al. Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship. Haematologica. 2010; 95(5): 708-15.
12. Russo R, Esposito MR, Asci R, Gambale A, Perrotta S, Ramenghi U, et al. Mutational spectrum in congenital dyserythropoietic anemia type II: identification of 19 novel variants in SEC23B gene. Am J Hematol. 2010; 85(12): 915-20.
13. Punzo F, Bertoli-Avella AM, Scianguetta S, Della Ragione F, Casale M, Ronzoni L, et al. Congenital dyserythropoietic anemia type II: molecular analysis and expression of the SEC23B gene. Orphanet J Rare Dis. 2011; 6: 89.
14. Russo R, Esposito MR, Iolascon A. Inherited hematological disorders due to defects in coat protein (COP)II complex. Am J Hematol. 2013; 88(2): 135-40.
15. Fermo E, Bianchi P, Notarangelo LD, Binda S, Vercellati C, Marcello AP, et al. CDAII presenting as hydrops foetalis: molecular characterization of two cases. Blood Cells Mol Dis. 2010; 45(1): 20-2.
16. Liu G, Niu S, Dong A, Cai H, Anderson GJ, Han B, et al. A Chinese family carrying novel mutations in SEC23B and HFE2, the genes responsible for congenital dyserythropoietic anaemia II (CDA II) and primary iron overload, respectively. Br J Haematol. 2012; 158(1): 143-5.
17. Amir A, Dgany O, Krasnov T, Resnitzky P, Mor-Cohen R, Bennett M, et al. E109K is a SEC23B founder mutation among Israeli Moroccan Jewish patients with congenital dyserythropoietic anemia type II. Acta Haematol. 2011; 125(4): 202-7.
18. Fromme JC, Orci L, Schekman R. Coordination of COPII vesicle trafficking by Sec23. Trends Cell Biol. 2008; 18(7): 330-6.
19. Stagg SM, LaPointe P, Razvi A, Gurkan C, Potter CS, Carragher B, et al. Structural basis for cargo regulation of COPII coat assembly. Cell. 2008; 134(3): 474-84.
20. Gurkan C, Stagg SM, Lapointe P, Balch WE. The COPII cage: unifying principles of vesicle coat assembly. Nat Rev Mol Cell Biol. 2006; 7(10): 727-38.
21. Russell C, Stagg SM. New insights into the structural mechanisms of the COPII coat. Traffic. 2010; 11(3): 303-10.
22. Hughes H, Stephens DJ. Assembly, organization, and function of the COPII coat. Histochem Cell Biol. 2008; 129(2): 129-51.
23. Paccaud JP, Reith W, Carpentier JL, Ravazzola M, Amherdt M, Schekman R, et al. Cloning and functional characterization of mammalian homologues of the COPII component Sec23. Mol Biol Cell. 1996; 7(10): 1535-46.
24. Wendeler MW, Paccaud JP, Hauri HP. Role of Sec24 isoforms in selective export of membrane proteins from the endoplasmic reticulum. EMBO Rep. 2007; 8(3): 258-64.
25. Boyadjiev SA, Fromme JC, Ben J, Chong SS, Nauta C, Hur DJ, et al. Cranio-lenticulosutural dysplasia is caused by a SEC23A mutation leading to abnormal endoplasmicreticulum-to-Golgi trafficking. Nat Genet. 2006; 38(10): 1192-7.
26. Fromme JC, Ravazzola M, Hamamoto S, Al-Balwi M, Eyaid W, Boyadjiev SA, et al. The genetic basis of a craniofacial disease provides insight into COPII coat assembly. Dev Cell. 2007; 13(5): 623-34.
27. Jones B, Jones EL, Bonney SA, Patel HN, Mensenkamp AR, Eichenbaum-Voline S, et al. Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet. 2003; 34(1): 29-31.
28. Tao J, Zhu M, Wang H, Afelik S, Vasievich MP, Chen XW, et al. SEC23B is required for the maintenance of murine professional secretory tissues. Proc Natl Acad Sci USA. 2012; 109(29): E2001-9.
29. van den Akker E, Satchwell TJ, Pellegrin S, Flatt JF, Maigre M, Daniels G, et al. Investigating the key membrane protein changes during in vitro erythropoiesis of protein 4. 2 (-) cells (mutations Chartres 1 and 2). Haematologica. 2010; 95(8): 1278-86.
30. Bruce LJ, Beckmann R, Ribeiro ML, Peters LL, Chasis JA, Delaunay J, et al. A band 3-based macrocomplex of integral and peripheral proteins in the RBC membrane. Blood. 2003; 101(10): 4180-8.
31. Townley AK, Feng Y, Schmidt K, Carter DA, Porter R, Verkade P, et al. Efficient coupling of Sec23-Sec24 to Sec13-Sec31 drives COPII-dependent collagen secretion and is essential for normal craniofacial development. J Cell Sci. 2008; 121(Pt 18): 3025-34.
32. Palmer KJ, Konkel JE, Stephens DJ. PCTAIRE protein kinases interact directly with the COPII complex and modulate secretory cargo transport. J Cell Sci. 2005; 118(Pt 17): 3839-47.
33. van den Akker E, Satchwell TJ, Pellegrin S, Daniels G, Toye AM. The majority of the in vitro erythroid expansion potential resides in CD34(-) cells, outweighing the contribution of CD34(+) cells and significantly increasing the erythroblast yield from peripheral blood samples. Haematologica. 2010; 95(9): 1594-8.
34. Satchwell TJ, Bell AJ, Pellegrin S, Kupzig S, Ridgwell K, Daniels G, et al. Critical band 3 multiprotein complex interactions establish early during human erythropoiesis. Blood. 2011; 118(1): 182-91.
35. Bell AJ, Satchwell TJ, Heesom KJ, Hawley BR, Kupzig S, Hazell M, et al. Protein distribution during human erythroblast enucleation in vitro. PLOS One. 2013; 8(4): e60300.
36. van den Akker E, Satchwell TJ, Williamson RC, Toye AM. Band 3 multiprotein complexes in the red cell membrane; of mice and men. Blood Cells Mol Dis. 2010; 45(1): 1-8.
37. Schmidt U, van den Akker E, Parren-van Amelsvoort M, Litos G, de Bruijn M, Gutierrez L, et al. Btk is required for an efficient response to erythropoietin and for SCF-controlled protection against TRAIL in erythroid progenitors. J Exp Med. 2004; 199 (6): 785-95.
38. von Lindern M, Deiner EM, Dolznig H, Parren-Van Amelsvoort M, Hayman MJ, Mullner EW, et al. Leukemic transformation of normal murine erythroid progenitors: vand c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis. Oncogene. 2001; 20(28): 3651-64.
39. Denecke J, Kranz C, Nimtz M, Conradt HS, Brune T, Heimpel H, et al. Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS). Glycoconj J. 2008; 25(4): 375-82.
40. Griffiths RE, Kupzig S, Cogan N, Mankelow TJ, Betin VM, Trakarnsanga K, et al. Maturing reticulocytes internalize plasma membrane in glycophorin A-containing vesicles that fuse with autophagosomes before exocytosis. Blood. 2012; 119(26): 6296-306.
41. Merryweather-Clarke AT, Atzberger A, Soneji S, Gray N, Clark K, Waugh C, et al. Global gene expression analysis of human erythroid progenitors. Blood. 2011; 117(13): e96-108.
42. Roux-Dalvai F, Gonzalez de Peredo A, Simo C, Guerrier L, Bouyssie D, Zanella A, et al. Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol Cell Proteomics. 2008; 7(11): 2254-69.
43. Kingsley PD, Greenfest-Allen E, Frame JM, Bushnell TP, Malik J, McGrath KE, et al. Ontogeny of erythroid gene expression. Blood. 2013; 121(6): e5-e13.
44. Vermylen C, Scheiff JM, Rodhain J, Ninane J, Cornu G. A variant of the congenital dyserythropoietic anaemia type II with structural abnormalities in the granulocytic series. Eur J Pediatr. 1986; 145(3): 232-5.
45. Heimpel H, Kellermann K, Neuschwander N, Hogel J, Schwarz K. The morphological diagnosis of congenital dyserythropoietic anemia: results of a quantitative analysis of peripheral blood and bone marrow cells. Haematologica. 2010; 95(6): 1034-6.
46. Skop AR, Liu H, Yates J 3rd, Meyer BJ, Heald R. Dissection of the mammalian midbody proteome reveals conserved cytokinesis mechanisms. Science. 2004; 305(5680): 61-6.
47. Fukuda MN. Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis. Baillieres Clin Haematol. 1993; 6(2): 493-511.
48. Chui D, Oh-Eda M, Liao YF, Panneerselvam K, Lal A, Marek KW, et al. Alpha-mannosidase-II deficiency results in dyserythropoiesis and unveils an alternate pathway in oligosaccharide biosynthesis. Cell. 1997; 90(1): 157-67.
49. Ishihara N, Hamasaki M, Yokota S, Suzuki K, Kamada Y, Kihara A, et al. Autophagosome requires specific early Sec proteins for its formation and NSF/SNARE for vacuolar fusion. Mol Biol Cell. 2001; 12 (11): 3690-702.
50. Wickramasinghe SN, Wood WG. Advances in the understanding of the congenital dyserythropoietic anaemias. Br J Haematol. 2005; 131(4): 431-46.
51. Wong KY, Hug G, Lampkin BC. Congenital dyserythropoietic anemia type II: ultrastructural and radioautographic studies of blood and bone marrow. Blood. 1972; 39(1): 23-30.